Nadeem, O., Aranha, M. P., Redd, R., Timonian, M., Magidson, S., Lightbody, E. D., . . . Ghobrial, I. M. Deeper response predicts better outcomes in high-risk-smoldering-myeloma: Results of the I-PRISM phase II clinical trial. Nature Portfolio.
Chicago Style (17th ed.) CitationNadeem, Omar, et al. Deeper Response Predicts Better Outcomes in High-risk-smoldering-myeloma: Results of the I-PRISM Phase II Clinical Trial. Nature Portfolio.
MLA (9th ed.) CitationNadeem, Omar, et al. Deeper Response Predicts Better Outcomes in High-risk-smoldering-myeloma: Results of the I-PRISM Phase II Clinical Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.